文献速递肝病消化道肿瘤与早癌

肝腺瘤病的自然史:一项长期观察性研究

Natural history of liver adenomatosis: A long-term observational study.
PubMed 文献 · J Hepatol · 2019-08-13

该单中心队列纳入40例肝腺瘤病(至少10个肝细胞腺瘤)患者,中位随访10.6年,评估其自然史与并发症风险。结果显示肝细胞腺瘤亚型多样,7例发生肝脏并发症(1例死亡、6例出血),4例出现肝外恶性肿瘤,提示该病异质性及密切管理的必要性。

要点

  • 肝腺瘤病以至少10个肝细胞腺瘤为特征,中位随访10.6年。
  • 7例发生肝脏并发症:1例死亡、6例出血(5例诊断时,1例妊娠期致命)。
  • 4例随访期间发生肝外恶性肿瘤,4例接受重复肝切除。

核心结论

  • 肝细胞腺瘤亚型多样及长期随访中出血和恶变的发生,凸显肝腺瘤病的异质性,需密切且特异的管理。
  • 生殖系HNF1A突变患者中,家族性肝腺瘤病在男女中发生率相当,男性出血率更高。

研究设计与样本

  • 单中心队列纳入40例肝腺瘤病(至少10个肝细胞腺瘤)患者,排除糖原贮积病,中位随访10.6(1.9-26.1)年。
  • 对手术标本或肝活检进行病理检查、免疫组化和分子生物学检测。

主要发现

  • 6例(15%)为家族性肝腺瘤病,均携带生殖系HNF1A突变;诊断中位年龄39(9-55)岁。
  • 肝细胞腺瘤亚型:46%HNF1A突变型、31%炎症型、3%sonic hedgehog型、8%未分类型;仅15%为混合型肝腺瘤病。
  • 肝脏并发症7例:1例(3%)肝移植后复发肝细胞癌死亡;6例(15%)出血,其中5例诊断时发生、1例妊娠期致命、2例为男性家族性肝腺瘤病。
  • 4例(10%)接受重复肝切除,4例(10%)随访期间发生肝外恶性肿瘤。

临床怎么用

  • 肝腺瘤病因其亚型多样及出血、恶变风险,需密切且特异的管理与随访。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Liver adenomatosis (LA) is characterized by the presence of at least 10 hepatocellular adenomas (HCAs), but the natural history of this rare liver disorder remains unclear. Thus, we aimed to reappraise the natural history and the risk of complications in a cohort of patients with at least 10 HCAs. METHODS: We analyzed the natural history of 40 patients with LA, excluding glycogen storage disorders, in a monocentric cohort. Pathological examination was performed, with immunostaining and molecular biology carried out on surgical specimens or liver biopsies. RESULTS: Forty patients (36 female) were included with a median follow-up of 10.6 (1.9-26.1) years. Six (15%) patients had familial LA, all with germline HNF1A mutations. Median age at diagnosis was 39 (9-55) years. Thirty-three (94%) women had a history of oral contraception, and 29 (81%) women had a pregnancy before LA diagnosis. Overall, thirty-seven (93%) patients underwent surgery at diagnosis. Classification of HCAs showed 46% of patients with HNF1A-mutated HCA, 31% with inflammatory HCA, 3% with sonic hedgehog HCA, 8% with unclassified HCA. Only 15% of the patients demonstrated a "mixed LA" with different HCA subtypes. Hepatic complications were identified in 7 patients: 1 patient (3%) died from recurrent hepatocellular carcinoma after liver transplantation; 6 (15%) had hemorrhages, of which 5 occurred at diagnosis, with 1 fatal case during pregnancy, and 2 occurred in male patients with familial LA. Four patients (10%) had repeated liver resections. Finally, 4 (10%) patients developed extrahepatic malignancies during follow-up. CONCLUSIONS: The diversity in HCA subtypes, as well as the occurrence of bleeding and malignant transformation during long-term follow-up, underline the heterogeneous nature of LA, justifying close and specific management. In patients with germline HNF1A mutation, familial LA occurred equally frequently in males and females, with a higher rate of bleeding in male patients. LAY SUMMARY: Liver adenomatosis is a rare disease characterized by the presence of 10 or more hepatocellular adenomas that may rarely be of genetic origin. Patients with liver adenomatosis have multiple adenomas of different subtypes, with a risk of bleeding and malignant transformation that justify a specific management and follow-up.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Barbier L, Nault JC, Dujardin F, et al. Natural history of liver adenomatosis: A long-term observational study. J Hepatol. 2019. PMID: 31419515. doi:10.1016/j.jhep.2019.08.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。